中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Pharmacokinetics of fucoidan and low molecular weight fucoidan from Saccharina japonica after oral administration to mice

文献类型:CNKI期刊论文

作者Jiaojiao TAN; Yimin SONG; Jing WANG; Ning WU; Yang YUE; Quanbin ZHANG
发表日期2023-09-15
出处Journal of Oceanology and Limnology
关键词fucoidan low molecular weight fucoidan pharmacokinetics bioavailability tissue distribution
英文摘要The brown seaweed,Sacchairna japonica,has been used in traditional Chinese medicine for over one thousand years.Oral administration of fucoidan or low molecular weight fucoidan (LMWF)from S.japonica could ameliorate kidney dysfunction in chronic kidney diseases and inhibit diabetic vascular complications.In many studies,LMWF was found to be more potent than fucoidan with high molecular weight.However,the pharmacokinetics of LMWF still remains unclear.The purpose of the research is to compare the pharmacokinetics of fucoidan with high molecular weight (136 kDa) with that low molecular weight (9.5 kDa) after oral administration to ICR mice.Since fucose is the main and representative monosaccharide of fucoidans,we evaluate the pharmacokinetics of fucoidan and LMWF by determining the fucose concentration in mice serum.Both fucoidan and LMWF were absorbed following oral administration.Fucoidan and LMWF were provided to mice by oral administration with 60 mg/kg and the maximum Concentration (C_(max)) was found at 2.5 h (0.66±0.32 mg/L) for Fucoidan and 1.5 h(1.01±0.56 mg/L) for LMWF,respectively.It seems that LMWF had a higher area under the curve(AUC_(0–t)) and was absorbed more quickly than fucoidan.The estimated bioavailability of LMWF was28.3%in the mice treated with a single dose of 30 mg/kg.In addition,LMWF was found widely spreaded into different tissues following oral administration and the highest concentration was found in kidney at 19.93±7.02μg/g.In this study,we first studied the pharmacokinetics of LMWF,in order to help to understand the function of LMWF.And our results shed light on the potential of development of drugs based on LMWF.
文献子类CNKI期刊论文
资助机构Supported by the National Natural Science Foundation of China (Nos. 42176137, 81872906) ; the Nantong Science and Technology Project (No. MS12021037) ; the STS Program of Chinese Academy of Sciences (No. KFJ-STS-QYZD-195) ; the K. C. Wong Education Foundation ; CAS
v.41期:05页:276-285
语种英文;
分类号R96
ISSN号2096-5508
源URL[http://ir.qdio.ac.cn/handle/337002/187007]  
专题中国科学院海洋研究所
作者单位1.KeyLaboratoryofExperimentalMarineBiology,CenterforOceanMega-Science,InstituteofOceanology,ChineseAcademyofSciences
2.LaboratoryforMarineBiologyandBiotechnology,NationalLaboratoryforMarineScienceandTechnology(Qingdao)
3.UniversityofChineseAcademyofSciences
4.DepartmentofPharmaceuticalEngineering,QingdaoUniversityofScienceandTechnology
5.LaboratoryforMarineDrugsandBiologicalProducts,NationalLaboratoryforMarineScienceandTechnology(Qingdao)
6.NantongZhongkeMarineScienceandTechnologyResearchandDevelopmentCenter
推荐引用方式
GB/T 7714
Jiaojiao TAN,Yimin SONG,Jing WANG,et al. Pharmacokinetics of fucoidan and low molecular weight fucoidan from Saccharina japonica after oral administration to mice. 2023.

入库方式: OAI收割

来源:海洋研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。